The API Industry Maintained Stable Growth And Good Development Trend, And The Imported Drug Market Continued To Expand

APIs are the final products obtained by upstream basic chemicals or animals and plants as basic raw materials, obtained by chemical synthesis or biological fermentation and extraction, and then chemically synthesized in 4-5 steps. In the downstream of APIs, APIs can be used in pharmaceutical preparations, feed, health products and cosmetics, and the most important application scenarios are in the field of pharmaceutical preparations. Among them, the characteristic APIs mainly correspond to drugs after the patent protection period, and the profit margin can still be maintained at a high level, and only a few enterprises can produce them.

The research and development of characteristic APIs usually begins 5 to 6 years before the expiration of the patent, and generic drug companies often cooperate with API companies to carry out the first imitation, and strive to be able to timely register and apply for registration and market sales within the time window of patent expiration, so as to obtain a larger market share.

In the past ten or twenty years, China's pharmaceutical market has continued to expand, and the API industry has maintained stable growth and a good development trend. However, there are still many R&D institutions and pharmaceutical companies that need to purchase imported APIs, imported APIs because of the many procedures involved in the whole chain, team experience, procedures, channels, transportation, customs declaration, etc., any of which will take a lot of time without resources or experience. Therefore, it is very important to choose an experienced foreign company to work with.